Funding for this research was provided by:
Sykehuset i Vestfold
Received: 18 January 2022
Accepted: 10 May 2022
First Online: 19 May 2022
: The Study was approved by The Regional Committees for Medical Research Ethics South East Norway and the Norwegian Medicines Agency before initiation. The Clinical Trial Unit at Oslo University Hospital monitored the project. All participants gave written informed consent according to the International Conference on Harmonization of Good Clinical Practice and the Helsinki Declaration. All patient data were anonymized.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form and report no conflicts of interest relevant to this article.